UnitedHealth Group Q2 2024 Adj EPS $6.80 Beats $6.66 Estimate, Sales $98.855B Beat $98.836B Estimate
Portfolio Pulse from Benzinga Newsdesk
UnitedHealth Group reported Q2 2024 adjusted EPS of $6.80, beating the estimate of $6.66. Sales were $98.855 billion, also surpassing the estimate of $98.836 billion.
July 16, 2024 | 9:56 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UnitedHealth Group's Q2 2024 adjusted EPS of $6.80 and sales of $98.855 billion both exceeded analyst estimates, indicating strong financial performance.
The company's better-than-expected earnings and sales figures suggest strong operational performance, which is likely to positively impact the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100